Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Health
Related: About this forumPermanent Injunction to Limit Distribution of Adulterated External Defibrillators
https://www.justice.gov/opa/pr/district-court-enters-permanent-injunction-against-philips-north-america-and-two-executivesDepartment of Justice
Office of Public Affairs
FOR IMMEDIATE RELEASE
Tuesday, October 31, 2017
District Court Enters Permanent Injunction Against Philips North America and Two Executives to Limit Distribution of Adulterated External Defibrillators
A federal court enjoined Philips North America LLC (Philips) and two of the companys executives from distributing certain medical devices, including some of the companys external defibrillators, until the company takes remedial steps, the Department of Justice announced today. The U.S. District Court for the District of Massachusetts entered a consent decree of permanent injunction against Philips, headquartered in Andover, Massachusetts, and two of the companys executives, Carla Kriwet and Ojas Buch. Ms. Kriwet is the business group leader for the Patient Care and Monitoring Solutions (PCMS) business group within Philips. Mr. Buch is Vice President, Head of Quality and Regulatory for the PCMS business group. With limited exceptions, the consent decree permanently enjoins the defendants from distributing certain medical devices until remedial steps are undertaken.
(snip)
The Department filed a complaint in the District of Massachusetts on Oct. 11, at the request of the U.S. Food and Drug Administration (FDA). As alleged in the complaint, FDA inspected Philips Bothell, Washington, facility in 2015. The inspection revealed that company had failed to establish and maintain adequate procedures for implementing corrective and preventive action as required by federal regulation. Specifically, the complaint alleged that while Philips initiated corrective and preventive action in response to complaints involving certain resistor failures during the use of the HeartStart HS1 and FRx defibrillators, Philips corrective actions did not fully address the problem with the devices in the field and Philips continued to receive complaints about the failure.
The complaint also alleged that another 2015 inspection by FDA at Philips Andover, Massachusetts, facility revealed the companys failure to establish and maintain adequate procedures for implementing corrective and preventive action in connection with the companys Q-CPR meter (a device that provides feedback on chest compressions during cardiopulmonary resuscitation), and for design verification in connection with a change to a battery used in the Heartstart MRx defibrillator.
The permanent injunction enjoins defendants, with limited exceptions, from manufacturing or distributing certain Emergency Care & Resuscitation devices until it can demonstrate that it has undertaken required remedial measures. The injunction also orders Philips to issue notifications with respect to its Q-CPR meters, and external defibrillators manufactured with a specific resistor. For the external defibrillators covered by the notice and still under warranty, Philips will provide a refurbished exchange unit at no cost; if the device is no longer under warranty, customers may be eligible for a trade-in rebate. Furthermore, the injunction requires Philips to take specific steps with respect to the companys other PCMS business units at its Andover and Bothell facilities. Those steps include hiring an expert consultant to inspect these business units to ensure, among other things, that the methods and controls used to manufacture and distribute Philips PCMS devices comply with the federal Food, Drug, and Cosmetic Act and its implementing regulations.
(snip)
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
3 replies, 1363 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (2)
ReplyReply to this post
3 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Permanent Injunction to Limit Distribution of Adulterated External Defibrillators (Original Post)
nitpicker
Nov 2017
OP
Response to nitpicker (Original post)
Name removed Message auto-removed
hlthe2b
(102,292 posts)2. How sad to see these malfunction...
One would think quality control would be paramount for Phillips. sigh...
justhanginon
(3,290 posts)3. Unfortunately, it seems today the paramount concern
for corporations is profit and their managements stock options price. All else is considered secondary. Whether it be in manufacturing or the financial industry the health or safety of the consumer comes in later, sometimes much later.